Gensight Biologics SA banner

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.1148 EUR 9.13% Market Closed
Market Cap: €27m

Wall St Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Wall Street analysts forecast SIGHT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SIGHT is 0.3111 EUR with a low forecast of 0.2121 EUR and a high forecast of 0.42 EUR.

Lowest Forecast
Price Target
0.2121 EUR
85% Upside
Average Forecast
Price Target
0.3111 EUR
171% Upside
Highest Forecast
Price Target
0.42 EUR
266% Upside
Gensight Biologics SA Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
3 452% / Year
Estimated Growth
Estimates Accuracy
-56%
Average Miss
N/A
Past Growth
3 452% / Year
Estimated Growth
Estimates Accuracy
-56%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 3 452%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SIGHT's stock price target?
Price Target
0.3111 EUR

According to Wall Street analysts, the average 1-year price target for SIGHT is 0.3111 EUR with a low forecast of 0.2121 EUR and a high forecast of 0.42 EUR.

What is the Revenue forecast for Gensight Biologics SA?
Projected CAGR
3 452%

The compound annual growth rate for Revenue over the next 3 years is 3 452%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett